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ABSTRACT
Objective: To determine the efficacy of hysteroscopic
endomyometrial resection in treating women with
intractable uterine bleeding.
Methods: A retrospective analysis was carried out on
304 women with intractable uterine bleeding treated
between August 1, 1991, and December 31, 1997.  The
average patient was 41.3 ± 8.0 years old and was fol-
lowed for a mean of 31.8 ± 22.1 months (range 6-75
months). 
Results: Eighty-three percent of women were amenor-
rheic at the time of their one-year follow-up.  The over-
all amenorrhea rate was 85.5%.  Only 0.8% of subjects
reported no improvement during the study period.
Histologic analysis of the endomyometrial specimens
revealed that 17 (5.6%) women were found to have sig-
nificant endometrial pathology not previously identified
with routine preoperative screening.  There was a total
of 20 complications (6.6%), although only 2 (0.7%) were
considered severe.  Twenty-seven women (8.9%) even-
tually required subsequent surgery during the study peri-
od.  Finally, 69 (22.7%) women with adenomyosis were
identified.  They did not appear to be at increased risk
for subsequent surgery.
Conclusions: Hysteroscopic endomyometrial resection
produces superior results as measured by amenorrhea
rates, the need for subsequent surgery and its low inci-
dence of associated complications; and it produces an
important histologic specimen.  For patients with signifi-
cant comorbidity, endomyometrial resection can be
adapted to a single-stage procedure incorporating the
diagnostic and treatment phases in women with abnor-
mal uterine bleeding.
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INTRODUCTION
The last 20 years have seen the development of many
new techniques for accomplishing endometrial destruc-
tion as a treatment choice for women with menorrhagia
and other forms of intractable uterine bleeding who
respond poorly to medical therapy.  Prior to the emer-
gence of these techniques, women’s choices were often
limited to hysterectomy or difficult lifestyle adjustments.
Endometrial destruction can be accomplished by either
coagulation or resection methods.  The former has been
accomplished utilizing a hysteroscope to accomplish
endometrial destruction under direct visual control.
Recently, several “blind,” or non-hysteroscopic, methods
have emerged with the thermal balloon being the first to
gain FDA approval. 
Currently available coagulation methods utilize laser
energy,1-4 electrosurgery,5-13 thermal balloon ablation14,15
and cryoablation.16 All suffer the same three drawbacks.
First, they do not provide a tissue specimen for histolog-
ic analysis.  Second, they generally require the use of
some form of preoperative medical therapy to produce
endometrial thinning.  Third, the success rates, as meas-
ured by amenorrhea and the need for subsequent sur-
gery, is suboptimal, ranging from a low of 15.2%15 to a
maximum of 55.4%.10 Only Taylor,13 who combined the
use of Nd:YAG laser for treatment of the uterine fundus
and the electrosurgical ball-end electrode for the remain-
der of the uterine cavity, reported a series of patients in
whom the amenorrhea rate at one year was 90%. 
The emergence of endometrial resection, first discussed
by DeCherney and Polan,17 and later by Magos et al,18,19
offered another surgical approach in which endometrial
tissue was actually removed.  The resection techniques
have the advantage of destroying tissue to a known
depth equal to the thickness of the specimen excised;
equivalent predictability of tissue destruction has yet to
be demonstrated with any coagulation methods.
Endometrial resection also provides an important histo-
logic specimen for analysis.18-22 At least three authors
have confirmed the presence of endometrial adenocarci-
noma in the resection specimens of women with previ-
ously unsuspected disease.12,20,22 Finally, unlike the
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coagulation methods, the resection methods may be per-
formed without utilizing expensive medical preparation
of the endometrium.  The major drawback of the resec-
tion methods lay in the poor amenorrhea rate reported.
Magos et al19 reported an amenorrhea rate of only 25%
on women followed to one year.
In 1994, the authors23 reported the technique of hystero-
scopic endomyometrial resection.  We described the first
systematic and geometrically efficient approach to excise
uterine endomyometrium to a depth of at least 3 mm.
Endomyometrial resection, like its forerunner endometri-
al resection, produces an excellent histologic specimen
that is readily oriented and does not require the use of
expensive medical preparatory agents.  The capacity to
avoid medical preparatory agents make it well suited to
the medically unstable patient in whom one may wish to
combine both diagnostic and operative hysteroscopy into
a single procedure, which limits the patient’s exposure to
anesthetic agents.  However, the aggressiveness of this
procedure in removing at least 3 mm of endomyometri-
um achieved a very high rate of amenorrhea (84% in our
first series of patients at six months of follow-up23).
This paper reviews the immediate and long-term out-
comes of the first 304 women to undergo endomyome-
trial resection.  For the purposes of this study, women
with leiomyomas presenting with intractable uterine
bleeding have been excluded, since they represent a very
heterogeneous group whose results have already been
reported by the authors.24
MATERIALS AND METHODS
Three hundred and four women with menorrhagia were
treated between August 1, 1991, and December 31, 1997.
All of the patients reported are derived either from the
authors’ private practice or referred from their gynecolo-
gists or family practitioners.  Each of the women in this
study underwent a complete history and physical exami-
nation.  Patients with clinical stigmata of thyroid disease
or hyperandrogenism had appropriate laboratory evalua-
tion.  The inclusion criteria for this study were women
with menorrhagia who wished to avoid hysterectomy and
appeared to have an anatomically normal uterus.  Women
with endometrial polyps were included in this study.  All
women with known leiomyomas or endometrial carcino-
ma were excluded from this study as were women with
known thyroid disease or hyperandrogenism.
Prior to July 1, 1993, all patients underwent a diagnostic
hysteroscopy.  After July 1, 1993, all patients underwent
a screening transvaginal ultrasound examination.
Women who were suspected of having an anatomic
abnormality, such as polyps or fibroids, also underwent
sonohysterography.  In all cases in which an endometri-
al polyp or a fibroid was suspected, a diagnostic hys-
teroscopy was performed.  Patients with leiomyomas of
any classification were excluded from this study; those
with endometrial polyps were not excluded.
Endometrial biopsies were carried out in 296 women.
Eight women had significant comorbidity, including
severe coronary artery disease, recurrent thromboembol-
ic episodes, unstable angina, cardiomyopathy, marked
obesity and disabling arthritis.  In these eight women,
endomyometrial resection was performed on an unpre-
pared uterine lining.  This approach enabled the authors
to combine the diagnostic and treatment phases of their
therapy without causing histologic alteration to the spec-
imen.
Office diagnostic hysteroscopy was carried out in 284
patients.  Ultrasound exams were carried out in 127
women, of whom 32 also underwent a sonohysterogram.
One hundred and fifteen patients underwent both a
transvaginal ultrasound and a diagnostic hysteroscopy.
All candidates for hysteroscopic endomyometrial resec-
tion were given a videotape and a pamphlet to review at
home that detailed the risks, consequences and alterna-
tives to this form of treatment.  A total of 304 patients
elected to undergo the procedure.
The endometrium was medically prepared in 215 of 304
(70.7%) patients.  Two hundred and one women (66.2%)
received a GnRH agonist one month prior to surgery; the
vast majority of them received leuprolide depot 3.75 mg
IM.  Several patients received oral contraceptives, depo-
medroxyprogesterone acetate, megestrol acetate and
danazol as a medical preparatory agent.  The remaining
89 (29.3%) patients received no endometrial preparation
whatsoever.  In general, patients did not receive leupro-
lide depot in the earlier years of the study because of
financial considerations.  During the earlier years, insur-
ance companies would not pay for the endometrial
preparatory agent.  Additionally, any woman with men-
orrhagia who was taking hormone replacement therapy
(HRT) was asked to discontinue her HRT prior to sur-
gery.Two hundred and forty-two (79.67%) procedures were
carried out in a free-standing ambulatory surgery center
while the remaining 62 were performed in a hospital out-
patient department.  All eight patients with significant
medical morbidities were scheduled at a hospital outpa-
tient department.  The remaining patients were assigned
to an ambulatory surgery center or a hospital outpatient
department based solely on operating room availability.
All procedures were performed by the first author.
Twenty-seven (20.4%) procedures were performed with
simultaneous sonographic guidance; employed whenev-
er a minimum uterine wall thickness (Figure 1) fell
below 12 mm, as noted on sagittal ultrasound scan.  All
ultrasound guidance was performed using either a 5200
S Invision equipped with a 3.5 MHz abdominal trans-
ducer (Acoustic Imaging Technology Corp; Phoenix, AZ)
or a similarly equipped Ultramark IV (ATL; Bothell, WA)
in a technique previously described by the authors.24
General anesthesia was used in all but a handful of cases.
Several patients requested and received a spinal anes-
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thetic.  In each case, a maximum allowable fluid absorp-
tion limit (MAFAlimit) was established for each patient
based on the formula MAFAlimit = 17.6 mL/kg,25
Adherence to the MAFAlimit provides adequate reassur-
ance that serum sodium concentrations will decrease no
more than 10 mEq/L whenever glycine 1.5% is utilized as
a distention medium.
The original technique of endomyometrial resection was
reported on a series of 35 patients23 who had not
received any form of endometrial preparation.  All of
these patients are included in this report.
Cervical dilatation was performed exclusively with
mechanical dilators until January 1, 1997.  After that date,
all patients underwent placement of a laminaria japonica
(2 or 3 mm) 15-24 hours prior to surgery.  In our origi-
nal paper, we describe the use of intraoperative vaso-
pressin administered by intracervical injection.  After
January 1995, we reduced the total dose from 10 units to
5 units.  Various resectoscopes were used throughout this
series, most commonly a 26 Fr continuous flow resecto-
scope (Karl Storz Endoscopy model no 27040 SL; Culver
City, California) fitted with an 8 x 5-mm loop electrode
or a 25 Fr (Circon, Stamford Connecticut) fitted with a 24
Fr loop electrode.
A gravity-fed system was used throughout the series.  A
Level 1 Fluid Warmer (Level 1 Technologies; Marshfield,
MA) was employed in more than half of all cases.
Glycine 1.5% was used in 256 (84.2%) patients.  Mannitol
5% was employed in 48 (15.8%) patients.  Various fluid
collection systems were used throughout our series.  The
most efficient, however, was the Urocatcher system
(MDT Castle No. S4004FTB MDT Corp; Rochester, NY )
and supporting hoop (Amatech Accessory S-N18006;
Amatech Corp; Acton, MA) in conjunction with a series
of 2 L containers connected to wall suction set at 150 mm
Hg.  A variety of electrosurgical generators were used to
produce a pure cutting waveform in power settings rang-
ing from 30-210 watts (x = 118 watts).  Settings were
judged adequate when the loop could be moved at 3
cms/sec without the sensation of tissue drag.
Dissection began on either the anterior or posterior uter-
ine wall (Figure 2).  The 8-mm loop electrode was
extended 1 cm and brought to the mid-fundus, then
buried into the endomyometrium to its full 5-mm depth.
The entire assembly was held in that position and
brought through the endocervical canal to the exocervix
Figure 1. Demonstration of minimum uterine wall thickness.Hysteroscopic Endomyometrial Resection, Wortman M et al.
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in approximately half of all patients.  During the last few
years, the dissection was terminated at the internal os.
The dimensions of each strip were checked to be certain
that at least 3 mm of uterine endomyometrium had been
removed.  Each strip was individually removed from the
uterine cavity prior to proceeding with the next step.  The
anterior cardinal strip of tissue23 was followed by resec-
tion of the posterior and the two lateral cardinal strips.
The anterior and posterior strips might join at the fundus
or be separated by 5-8 mm of endomyometrium.  The lat-
eral cardinal strips begin 5 mm proximal to each tubal
ostia.  The removal of all four cardinal strips produces a
hysteroscopic and sonographic appearance of a “four leaf
clover” (Figure 3).  The resultant anterolateral and pos-
terolateral triangles (Figure 4) are resected followed by
removal of the “ridge tissue.”  This process is continued
until at least 3 mm of endomyometrium have been
removed from all but the fundus.  Various methods were
used to remove the remaining fundal tissue.  Most often,
the loop was reconfigured to 160 degrees and narrowed
as required.  In this configuration, the loop was used to
resect all of the remaining endometrial tissue beginning
at the midline and sweeping laterally past each tubal
ostium.  All remaining ridge tissue was sculpted so that
at least 3 mm of tissue was removed, allowing 2 mm of
resection at the tubal ostia (Figure 5). 
The first 130 patients (42.8%) underwent rollerball coag-
ulation of the exposed myometrium at power settings
ranging from 70 to 120 watts of coagulation current.  The
next 174 patients did not undergo any coagulation using
a rollerball electrode.  In 25/174 cases, however, the wire
loop was used with power settings ranging from 50-120
watts (x = 97.6 watts) of coagulation current to fulgurate
isolated bleeders.  All patients received prophylactic
antibiotics.  Patients who were not penicillin-allergic
received cefonicid 1 gram IVSS or cefazolin sodium 1
gram IVSS intraoperatively.  The remaining subjects
received either doxycycline 100 mg IVSS or gentamicin
80 mg IVSS.  Patients were discharged on a five-day
Figure 2. Resection of the posterior cardinal strip. Figure 3. Demonstration of “4 leaf clover” after all 4 cardinal
strips have been removed.course of doxycycline 100 mg bid and ibuprofen 800 mg
q 6 h prn.  Some patients required acetaminophen and
codeine.
All patients were seen two weeks postoperatively.
During the last year of the study, routine ultrasound
examinations were carried out at a six-month postopera-
tive visit.  Additionally, all of our patients were asked to
return for a transvaginal ultrasound examination as part
of their annual follow-up in order to identify any evi-
dence of hematometra or endometrial regrowth.
Follow-up data was obtained at the time of routine annu-
al exams on the majority of patients.  For those patients
who were followed by their referring physicians, such
data was obtained by telephone calls at specified inter-
vals.  Amenorrhea, hypomenorrhea and moderate
improvement have been defined in our original paper.23
Finally, all of the pathology specimens, including the
preoperative endometrial biopsies, were reviewed by
one of two pathology departments: the University of
Rochester Department of Pathology or the Highland
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Hospital Department of Pathology (the latter is an affili-
ate of the U of R).  A statistical analysis was carried out
in order to compare the outcomes of patients found to
have adenomyosis, diagnosed at the time of their initial
surgery, with patients whose pathology specimens did
not reveal adenomyosis.
RESULTS
A total of 304 women underwent hysteroscopic endomy-
ometrial resection.  Their average age was 41.3 ± 8 years
(range 26-77 years).  They were followed for an average
of 31.8 ± 22.1 months (range 6-75 months).  The average
surgical time was 23.4 ± 12.6 minutes (range 4-90 min-
utes).  The average amount of distention fluid used was
8,959 ± 4,575 mL (range 1,000-24,900 mL).  The average
amount of fluid absorbed was 472 ± 504 mL (0-2500 mL)
The menstrual outcomes as a result of their initial surgi-
cal procedures are presented in Figure 6.  The overall
amenorrhea rate was 85.5%.
Two hundred and seventy-seven patients (91.1%)
required no additional procedures during the study peri-
od.  Twenty-seven women (8.9%) underwent subsequent
retreatment or hysterectomy; the mean interval between
the initial and subsequent therapy was 31.8 ± 16.3
months (range 8-66 months).  Thirteen women (4.3%)
underwent repeat hysteroscopic procedures; the reasons
are summarized in Table 1.  The average age at the time
of initial surgery among these 13 women was 41.0 ± 5.5
years (range 28-52 years).  Six of 13 patients undergoing
retreatment had continued vaginal bleeding; 4 had symp-
tomatic hematometra without vaginal bleeding.  An addi-
tional 8 patients had uterine pain of unknown etiology.
As a result of retreatment, 4 of 6 patients with continued
vaginal bleeding (66.7%) became amenorrheic and 2
(33.3%) became hypomenorrheic.  Three of the 8 women
with pain of unknown etiology eventually had hysterec-
tomies.  The remaining 5 became pain free.
A total of 17 (5.6%) subjects ultimately required hys-
terectomies (Table 2); two were performed because of
previously unsuspected adenocarcinoma of the
endometrium.  Thus, only 15 (5.0%) required hysterecto-
my because of method failure.
An analysis of repeat procedures and hysterectomies as
a function of age revealed that 4 repeat procedures and
8 hysterectomies were performed in the 131 women who
were less than 40 years old at the time of their initial sur-
Figure 4. Demonstration of both anterolateral and both pos-
terolateral triangles.Hysteroscopic Endomyometrial Resection, Wortman M et al.
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gery (9.61%).  Of the 173 women who were 40 or older
at the time of their initial surgery 9 patients had subse-
quent repeat hysteroscopic procedures, and 6 women
had subsequent hysterectomies (8.67%).
There were immediate complications in 12 (3.9%)
patients.  Seven patients (2.3%) suffered an inadvertent
uterine rupture or perforation.  In 5 of the 7 patients,
however, the procedure was completed without difficul-
ty.  The other two had an incomplete procedure resulting
in only moderate menstrual improvement; one eventual-
ly did require a hysterectomy.  When complications were
stratified according to patient age, it was noted that 9 of
the complications occurred in the 131 women who were
less than 40 years of age (6.87%), while 3 of the compli-
cations occurred in the 173 women whose age was equal
to or greater than 40 (1.73%).  Interestingly, 6 of the 7
uterine ruptures or perforations happened in the younger
age group.
Two patients had excessive fluid absorption with sodium
concentrations of 116 and 127 mEq/L.  Both patients
were treated with diuretics and fluid restriction.  Each
was discharged within six hours postoperatively.  Three
women required uterine tamponade with a foley catheter
because of excessive postoperative bleeding.  One of
these women required admission for 24 hours and was
discharged without sequelae.  None of these complica-
tions were judged to be severe.
There were six delayed complications.  These included
two patients with confirmed myometritis.  One was hos-
pitalized and treated with parenteral antibiotics, and the
other responded well to outpatient therapy with oral
antibiotics.  There were two other women who present-
ed with low grade fever, increased vaginal bleeding and
pelvic pain.  Myometritis was suspected, but neither had
a leukocytosis or positive cervical culture; however, both
improved rapidly with oral antibiotic therapy.  A fifth
patient presented two weeks postoperatively with diar-
rhea secondary to Clostridium difficile toxin.  She
responded well to oral metronidazole.  A sixth patient
presented with a tubo-ovarian abscess during her 7th
postoperative week and underwent an exploratory
laparotomy and left salpingoophorectomy.  Two of the
six patients did require hospitalization.  Both of these
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Table 1.
Indications for repeat hysteroscopic procedures.
N = 13
Cyclic Cyclic  Constant Pain Pain  Hemato- Cervical  Hemato-
bleeding spotting vaginal  ?etiol. relieved with  metra stenosis
salpinx
bleeding passing of  U/S 
clots
1x
2x x x
3 x
4x x
5x
6x
7x
8x x x
9x x
10 x x
11 x x
12 x x
13 x x
Figure 6. Menstrual outcomes of 304 women undergoing
endomyometrial resection (EMR).
complications were judged to be severe (0.66%).
The results of the 296 preoperative endometrial biopsies
are summarized in Table 3.  Seven women (2.4%) were
diagnosed with simple hyperplasia.  Two were treated
with depot-leuprolide acetate 3.75 mg IM one month
prior to surgery; one woman was treated with oral con-
traceptives, while the remaining four patients were not
treated with any form of medical preparation.  None of
these women had any residual hyperplasia at the time of
their endomyometrial resection.  There were two other
women whose endometrial biopsies revealed complex
hyperplasia, both of whom received leuprolide acetate
and both of whom were subsequently found to have
adenocarcinoma of the endometrium after their endomy-
ometrial resection (Table 4).
Postoperative histological analysis was carried out on all
304 women’s tissue specimens (Table 4), the mean
weight of which was 12.3 ± 8.6 g (range 2-63 g).
Adenomyosis was discovered in 69 patients (22.7%), 7 of
whom were considered to have severe adenomyosis,
defined as adenomyosis extending to the resection mar-
gin.  Of the 69 women whose initial specimens revealed
adenomyosis, 9 (13.0%) had some form of subsequent
surgery.  Of the 235 women whose initial specimenswere devoid of adenomyosis, 18 (7.7%) went on to
require additional treatment.  The presence of adeno-
myosis did not increase the risk of subsequent surgery (P
= 0.17).
Fourteen (4.6%) of the 304 subjects had endometrial
hyperplasia; none of these were suspected preoperative-
ly.  Eleven patients (3.6%) had simple hyperplasia and 3
(1.0%) had complex hyperplasia.
Another 3 (1%) patients were found to have adenocarci-
noma of the endometrium.  Preoperative biopsies
revealed that one of the three had focal complex hyper-
plasia, a second had focal areas of complex adenoma-
tous hyperplasia without atypia, and a third had a benign
endocervical polyp.  The first two patients had well-dif-
ferentiated adenocarcinoma of the endometrium and
were treated with hysterectomy and bilateral salpin-
goophorectomy.  They both remain free of disease at
Hysteroscopic Endomyometrial Resection, Wortman M et al.
204 JSLS(2000)4:197-207
Table 3.
Results of 296 preoperative endometrial biopsies.
Proliferative endometrium 147 (49.7%)
Secretory endometrium 97 (32.8%)
Menstrual endometrium 14 (04.7%)
Other 38 (12.8%)
Simple hyperplasia 7 (02.4%)
Complex hyperplasia 2 (00.7%)
*disorganized, pseudodecidual, inactive endometrium, blood,
mucous, fragments of benign endometrial polyp
Table 2.
Indications for women undergoing subsequent hysterectomy.
N = 17
Cyclic Cyclic  Constant Pain Hemato- Cervical  Well  Continued
bleeding spotting vaginal  metra stenosis differentiated bleeding
bleeding documented  Adeno after repeat
on ultrasound carcinoma
EMR
1x
2x x x
3x x
4x
5x
6x x
7x
8x
9x x
10 x
11 x
12 x
13 x
14 x
15 x
16 x
17 xJSLS(2000)4:197-207 205
their one- and two-year follow-up, respectively.  The
third patient was diagnosed with a FIGO Stage Ib grade
II adenocarcinoma of the endometrium infiltrating into
the superficial one-third of the myometrium following an
endomyometrial resection and polypectomy on
September 15, 1994.  Because of numerous incapacitat-
ing medical problems, she was treated with radiation
therapy alone.  In August of 1995, she presented with a
large pelvic mass consistent with a poorly differentiated
adenocarcinoma of the endometrium and died in April
1996.
DISCUSSION
This new method of hysteroscopic endomyometrial
resection, first reported in 1994,23 removes a specimen at
least 3 mm in depth.  Unlike the methods of
DeCherney17 and Magos et al,18,19 the specimens are long
continuous strips of uniform depth and width.  Mago’s
technique seeks “to excise tissue to include 1-2 mm of
myometrium.”19 This difference is underscored by com-
paring the mean specimen weight obtained from our
procedure, 12.3 g (range 2-63 g), and Magos’, 6.67 g
(range 0.98-45 g).19
The size of the specimen is important, as it provides ade-
quate material for histologic analysis.  In this series of
304 women, 17 (5.6%) had significant endometrial
pathology that were missed on preoperative endometrial
sampling.  These abnormalities ranged from simple
hyperplasia (3.6%) and complex hyperplasia (1%) to ade-
nocarcinoma (1%).  In addition, 69 women (22.7%) were
found to have adenomyosis that was previously unsus-
pected.  The completeness of the histologic specimen
allows this procedure to be adapted to women with sig-
nificant comorbidity.  The surgeon may, in selected
cases, perform both a diagnostic and operative hys-
teroscopy provided that the patient has not received any
medications capable of altering endometrial histology.
The aggressiveness of this procedure did not appear to
adversely affect its complication rate.  The short-term and
long-term complication rate was found to be 6.2%, with
only 3.9% occurring immediately.  The rate of severe
complications was 0.66%, a figure quite acceptable given
the nature of these complications.
The procedure is very efficacious in treating intractable
uterine bleeding.  In our first study, we reported an
amenorrhea rate, at 6 months, of 84%.23 The present
study reveals an overall amenorrhea rate of 85.5% in a
large group of women who have been followed for an
average of 31.8 months.  As shown in Table 5, this is the
highest rate among all of the major endometrial ablation
or resection studies published to date.
Several authors20,21,26 have published their results by
incorporating measures of “patient satisfaction.”  It is
worth noting that we do not include such subjective
measures, which are unreliable and of limited value.  The
measurement of ‘patient satisfaction’ allows for the intro-
duction of a selection bias when offering a particular
treatment modality.  If operative candidates realize that a
particular method of endometrial ablation or resection
produces a 25% likelihood of overall amenorrhea, many
will select themselves out of this treatment regimen leav-
ing a study population likely to be less fastidious and
more easily satisfied about the requirements of their
menstrual outcomes compared to ones that opted out of
the study.  By measuring amenorrhea rates, we may
compare the outcomes of different operative modalities
provided that the populations under consideration are
similar in terms of age and pathology (eg, the presence
or absence of fibroids).  The authors prefer to compare
different modalities by measuring amenorrhea rates at a
Table 4.
Histologic analysis of endomyometrial resection specimens.
N = 304
Endometrium
Proliferative 175 (57.2%)
Secretory 79 (29.6%)
Menstrual 5 (01.7%)
Other 26 (08.6%)
No significant pathology 19 (06.3%)
Simple hyperplasia 11 (03.6%)
Complex hyperplasia 3 (1.0%)
Adenocarcinoma 3 (1.0%)
Myometrium
Adenomyosis 69 (22.7%)
Severe adenomyosis 7 (02.3%)
Unremarkable 235 (77.3%)Hysteroscopic Endomyometrial Resection, Wortman M et al.
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specific time interval (6, 12, 24 months) on populations
with similar age characteristics and on women with
anatomically normal uteri—that is, without fibroids.
The importance of comparing groups with similar age
characteristics cannot be overstated.  Pyper et al21 noted
that the “success rate [of endometrial resection] was lower
in the 13 women under 40 years old (46%), in contrast to
55% for the 58 women between 40 years and 49 years
and 78% for the 9 women who were 50 years or more.”
Vilos12 and Garry3 also observed a positive correlation
between age and increasing amenorrhea rates.  Thus,
Brooks et al27 were able to report a one-year amenorrhea
rate of 88% by performing resectoscopic endometrial
ablation in a study population whose average age was 54
(range 50-71).
The length of follow-up must also be considered when
comparing the success rates of different modalities.
Seeras et al28 reported a resumption of menstruation,
after a 6-12 month interval of amenorrhea, in 27.2% of
amenorrheic patients undergoing either endometrial
ablation or resection.  Rutherford et al16 showed a dra-
matic fall in amenorrhea rates from 6 months (75.5%) to
22 months (50.3%) of follow-up.  Based on Rutherford’s
data, as well as our own, it might be reasonable to sur-
mise that at least three years are required to draw con-
clusions about the eventual success of any procedure.  In
our study, three years was the mean time for follow-up
on the retreatment cases.
The high rate of amenorrhea coupled with the low rates
of retreatment and subsequent hysterectomy in the pres-
ent study of 304 patients, followed for up to 6 years,
demonstrate that hysteroscopic endomyometrial resec-
tion is far more efficacious than other methods of
endometrial destruction in women with menorrhagia that
Table 5.
Comparing the major studies on endometrial ablation, endometrial resection and endomyometrial resection.
N follow-up mean age  Amen Repeat Hyst %
mean (range) yr. rate proced%
Endometrial ablation techniques, hysteroscopic
Laser
3Garry et al 600 15 mos (6-42) 43±N. A. 28.9% 14.3% 6.8% 
Rollerball
11Chullapram et al 128 n.a. (12-52 mos) 40.9 ± 6.1 25% 8.5% 8.5%
9Paskowitz 200 30 mos (n.a.) n.a. 40% 4.0% 5.0%
10Wortman 65 12 mos 38.2 55.4% N.A. N.A
Endometrial ablation techniques, non-hysteroscopic (“global”)
Cryoablation
16Rutherford et al 15 22 mos (22 mos) 47.0 ± N.A. 50.3% 6.7% ---
Thermal balloon
14Vilos et al 68 12 mos 39 ± 6 20.6% 20.6% 4.2%
15 Meyer WR et al 125 12 mos 40.5  15.2% ---- 1.6%
Endometrial Resection (TCRE)
19Magos et al 113 12 mos 42.3 25% 7.0% 4.0%
20Rankin L et al 363 3-4 mos 45 (24-72) N.A. 7.5% 6.8%
Combination ablation and resection techniques
12Vilos GA 728 12 mos 41 ± 7 60% 4.4% 2.5%
Endomyometrial Resection (EMR)
aWortman et al 304 31.8 (6-75 mos) 41.3 ± 8.0 85.5% 4.3% 5.0%
a = author’s serieshave thus far been described.  Moreover, this method is
no less safe than other methods.
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